APP and Alzheimer disease: Interestingly, we observed that explorative Y-maze alternation score of APP/PS1 animals injected with AAV-SNX8 was markedly improved compared those injected with AAV controls (Figure 6C), indicating that SNX8 overexpression can ameliorate behavioral alternation phenotypes in AD models.